Immune Clinical Trials in Hangzhou, Zhejiang
19 recruitingHangzhou, Zhejiang, China
Showing 1–19 of 19 trials
Recruiting
Phase 3
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Immune Thrombocytopenic Purpura (ITP)
Takeda171 enrolled112 locationsNCT06722235
Recruiting
Phase 3
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Immune Thrombocytopenic Purpura (ITP)
Takeda150 enrolled108 locationsNCT06948318
Recruiting
Phase 2Phase 3
Pirfenidone Capsules in the Treatment of Radiation-induced Lung Injury With or Without Immune Pneumonia
Radiation Induced Lung InjuryImmune-related Pneumonia
Beijing Continent Pharmaceutical Co, Ltd.298 enrolled36 locationsNCT07388680
Recruiting
Early Phase 1
Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease
IgA Nephropathy (IgAN)Autoimmune DiseasesSystemic Sclerosis (SSc)+3 more
The Children's Hospital of Zhejiang University School of Medicine15 enrolled1 locationNCT07507201
Recruiting
Not Applicable
Electroacupuncture Regulation of Immune Cells in Herpes Zoster
ElectroacupunctureHerpes ZosterImmune
First People's Hospital of Hangzhou8 enrolled1 locationNCT06643247
Recruiting
Early Phase 1
Exploratory Clinical Study of Second-generation CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in Treating Paediatric B Cell-related Autoimmune Diseases
CARAutoimmune DiseasesPaediatric B Cell-related Autoimmune Diseases
The Children's Hospital of Zhejiang University School of Medicine12 enrolled1 locationNCT07283315
Recruiting
Phase 1
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
IgA Nephropathy (IgAN)Autoimmune DiseasesSystemic Sclerosis (SSc)+3 more
The Children's Hospital of Zhejiang University School of Medicine15 enrolled1 locationNCT07305116
Recruiting
Early Phase 1
Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease
Autoimmune DiseasesSystemic Lupus ErthematosusMulti-Drug Resistant Nephrotic Syndrome+1 more
The Children's Hospital of Zhejiang University School of Medicine36 enrolled1 locationNCT06792799
Recruiting
A Prospective Study to Evaluate Clinical Outcomes in Anti-LGI1 Encephalitis
Autoimmune EncephalitisLeucine-Rich Glioma Inactivated 1 Autoimmune Encephalitis
Shen Chun-Hong60 enrolled1 locationNCT06173076
Recruiting
Neural Autoantibody Prevalence in New-onset Focal Seizures of Unknown Etiology
EpilepsyEncephalitis Autoimmune
Shen Chun-Hong300 enrolled1 locationNCT06388161
Recruiting
Construction and Clinical Application of the Immune Map of Pancreatic Cancer Evolution
Pancreas CancerImmune Evasion, Tumor
First Affiliated Hospital of Zhejiang University1,500 enrolled1 locationNCT07034339
Recruiting
Phase 3
A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia
Primary immune thrombocytopenia
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.199 enrolled53 locationsNCT06900920
Recruiting
Immunoprofilling of Peripheral Blood Mononuclear Cells in Children With Attention Deficit/Hyperactivity Disorder
Immune SystemADHDClinical Syndrome
First Affiliated Hospital of Zhejiang University100 enrolled1 locationNCT06109337
Recruiting
Not Applicable
Exploratory Study on the Efficacy of Betaine Hydrochloride in Treating Autoimmune Gastritis
Autoimmune Gastritis
Second Affiliated Hospital, School of Medicine, Zhejiang University100 enrolled1 locationNCT06881511
Recruiting
Phase 2
Nivolumab Combined With SOX Used in the Perioperative Treatment
Gastric CancerImmune Suppression
Xiangdong Cheng46 enrolled1 locationNCT05739045
Recruiting
Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry
Autoimmune DiseasesAutoinflammatory Diseases
Peking Union Medical College Hospital20,000 enrolled9 locationsNCT06417502
Recruiting
Phase 3
Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia
Chronic Primary Immune Thrombocytopenia (ITP)
Beijing InnoCare Pharma Tech Co., Ltd.195 enrolled45 locationsNCT06004856
Recruiting
A Clinical Study on the Analysis of Risk Factors for the Occurrence of PD-1/PD-L1 Inhibitor-associated Liver Injury in Lung Cancer Patients
Immune Checkpoint InhibitorsLiver Injury
Zhejiang University2,000 enrolled1 locationNCT06402981
Recruiting
Early Phase 1
CD19-BAFF CAR-T Cells Therapy for Patients With Autoimmune Diseases
Autoimmune Diseases
Zhejiang University45 enrolled1 locationNCT06279923